Palliative Radiotherapy
description
Transcript of Palliative Radiotherapy
![Page 1: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/1.jpg)
![Page 2: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/2.jpg)
Palliative Palliative RadiotherapyRadiotherapy
![Page 3: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/3.jpg)
“the active total care of patients whosedisease is not responsive to curative treatment ….” WHO
![Page 4: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/4.jpg)
About 30-45 % of About 30-45 % of patients receiving patients receiving radiotherapy are radiotherapy are palliativepalliative
![Page 5: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/5.jpg)
GOALS OF PALLIATIVE GOALS OF PALLIATIVE RTRT control symptoms enhance quality of life optimize the patient’s limited
remaining time
guided by basic ethical principles and clinical based evidence
![Page 6: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/6.jpg)
EMERGENCY EMERGENCY INDICATIONS:INDICATIONS: Spinal cord compression Haemorrhage/bleeding Superior Vena caval obstruction Seizures/ Fitting
![Page 7: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/7.jpg)
INDICATIONSINDICATIONS Pain relief from bone mets. Prevention of pathological # Spinal cord compression. Impending or actual obstruction
hollow viscera. Brain mets. Control of Haemorrhage. Control of ulceration/ fungation.
![Page 8: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/8.jpg)
FractionFraction A single treatment sessionA single treatment sessionConventionally 1.8 – 2.0 GyConventionally 1.8 – 2.0 Gy
![Page 9: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/9.jpg)
HypofractionationHypofractionationFewer fractions than Fewer fractions than conventionalconventionalHigher dose per fractionHigher dose per fractionShorter treatment timeShorter treatment timeIncreased probability of late Increased probability of late effectseffectsDecreased radiotherapy waiting Decreased radiotherapy waiting timestimes
![Page 10: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/10.jpg)
HypofractionationHypofractionation
clinical evidence suggests that shorter fractionation schedules compared to more protracted schedules have the same effectiveness in symptom control of incurable cancer patients, particularly, for metastatic bone pain and multiple brain metastases.
![Page 11: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/11.jpg)
Bony MetastasesBony Metastases
![Page 12: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/12.jpg)
Bony mets can cause:Bony mets can cause: PainPain Pathological fracturePathological fracture Spinal cord compressionSpinal cord compression HypercalcemiaHypercalcemia
Leading to debilitation and Leading to debilitation and impaired quality of lifeimpaired quality of life
![Page 13: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/13.jpg)
External beam radiation provides External beam radiation provides significant relief in 50-80% of significant relief in 50-80% of patients and complete pain relief patients and complete pain relief in 30 % of patients (ASTRO)in 30 % of patients (ASTRO)
![Page 14: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/14.jpg)
Factors affecting Factors affecting choice of fractionation choice of fractionation regimenregimen Performance statusPerformance status PrognosisPrognosis Risk for fracture or cord Risk for fracture or cord
compressioncompression Site to be treatedSite to be treated
![Page 15: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/15.jpg)
A literature review confirms similar A literature review confirms similar rates of pain control using a single rates of pain control using a single fraction versus a multiple fractions (50-fraction versus a multiple fractions (50-85%). There are however higher 85%). There are however higher retreatment rates for single fraction retreatment rates for single fraction regimens. regimens.
![Page 16: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/16.jpg)
Fractionation Fractionation regimensregimens 8 Gy in 1 fraction8 Gy in 1 fraction 20 Gy in 5 fractions20 Gy in 5 fractions 30 Gy in 10 fractions30 Gy in 10 fractions 24 Gy in 6 fractions24 Gy in 6 fractions
Endpoints using pain relief, narcotic Endpoints using pain relief, narcotic relief and quality of life measures show relief and quality of life measures show consistent similarity in the regimens consistent similarity in the regimens
![Page 17: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/17.jpg)
![Page 18: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/18.jpg)
The frequency and severity of side The frequency and severity of side effects especially mucosal are a effects especially mucosal are a more of a function of radiation more of a function of radiation planning than radiotherapy dose planning than radiotherapy dose
![Page 19: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/19.jpg)
BRAIN METASTASESBRAIN METASTASES
![Page 20: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/20.jpg)
![Page 21: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/21.jpg)
Comparison of median survival in 7 studies using the recursive partitioning analyses (RPA) classes (treatment was WBRT with or without local measures, none of the studies is limited to one particular cancer type).
![Page 22: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/22.jpg)
Clinical Clinical Recommendations of Recommendations of DEGRODEGRO
Breast Care (Basel). 2010; 5(6): 401–407. Published online 2010 December 8. doi: 10.1159/000322661
![Page 23: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/23.jpg)
““Analysis of all included patients, SRS plus WBRT, did Analysis of all included patients, SRS plus WBRT, did not show a survival benefit over WBRT alone. not show a survival benefit over WBRT alone. However, performance status and local control were However, performance status and local control were significantly better in the SRS plus WBRT group. significantly better in the SRS plus WBRT group. Furthermore, significantly longer OS was reported in Furthermore, significantly longer OS was reported in the combined treatment group for RPA Class I the combined treatment group for RPA Class I patients as well as patients with single metastasis.”patients as well as patients with single metastasis.”
Cochrane Database Syst Rev. 2010 Jun 16;(6):CD006121.Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain
metastases
![Page 24: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/24.jpg)
conventional fractionation can be conventional fractionation can be used to avoid late neurotoxicity used to avoid late neurotoxicity
dexamethasone is the dexamethasone is the corticosteroid of choice for corticosteroid of choice for cerebral edemacerebral edema
anticonvulsants should not be anticonvulsants should not be prescribed prophylactically prescribed prophylactically
![Page 25: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/25.jpg)
Spinal cord Spinal cord compressioncompression
![Page 26: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/26.jpg)
Inform patients at high risk of developing bone metastases, patients with diagnosed bone metastases, or patients with cancer who present with spinal pain about the symptoms of MSCC
(NICE)(NICE)
![Page 27: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/27.jpg)
• pain in the middle (thoracic) or upper (cervical) spine • progressive lower (lumbar) spinal pain • severe unremitting lower spinal pain • spinal pain aggravated by straining (for example, at stool, or when coughing or sneezing) • localized spinal tenderness • nocturnal spinal pain preventing sleep
Patients with cancer and any of the following symptoms suggestive of spinal metastases should seek medical attention immediately for assessment:
![Page 28: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/28.jpg)
Patient should be nursed flat with neutral spine alignment (including ‘log rolling’ with use of a bed pan for toilet) until bony and neurological stability are ensured and cautious remobilisation may begin
![Page 29: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/29.jpg)
For patients with MSCC, once any spinal shock has settled and neurology is stable, carry out close monitoring and interval assessment during gradual sitting from supine to 60 degrees over a period of 3–4 hours
![Page 30: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/30.jpg)
Offer conventional analgesia (including NSAIDs, non-opiate and opiate medication) as required to patients with painful spinal metastases in escalating doses as described by the WHO three-step pain relief ladder
![Page 31: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/31.jpg)
Offer patients with vertebral involvement from myeloma or breast cancer bisphosphonates to reduce pain and the risk of vertebral fracture/collapse
![Page 32: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/32.jpg)
Unless contraindicated (including a significant suspicion of lymphoma) offer all patients with MSCC a loading dose of at least 16 mg of dexamethasone as soon as possible after assessment, followed by a short course of 16 mg dexamethasone daily while treatment is being planned
![Page 33: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/33.jpg)
If surgery is appropriate in patients with MSCC, attempt to achieve both spinal cord decompression and durable spinal column stability
Patients with MSCC who have been completely paraplegic or tetraplegic for more than 24 hours should only be offered surgery if spinal stabilisation is required for pain relief
![Page 34: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/34.jpg)
There should be urgent (within 24 hours) access to and availability of radiotherapy and simulator facilities in daytime sessions, 7 days a week for patients with MSCC requiring definitive treatment or who are unsuitable for surgery
![Page 35: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/35.jpg)
Fractionation Fractionation regimensregimens 8 Gy in 1 fraction8 Gy in 1 fraction 20 Gy in 5 fractions20 Gy in 5 fractions 30 Gy in 10 fractions30 Gy in 10 fractions 24 Gy in 6 fractions24 Gy in 6 fractions
![Page 36: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/36.jpg)
![Page 37: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/37.jpg)
Palliative Palliative radiotherapy a slice radiotherapy a slice of the palliative pieof the palliative pie
![Page 38: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/38.jpg)
Palliative radiotherapy Palliative radiotherapy should be aimed as a should be aimed as a “one stop approach”“one stop approach”
![Page 39: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/39.jpg)
Factors affecting Factors affecting utilization of palliative utilization of palliative radiotherapy servicesradiotherapy services Poor performance statusPoor performance status Short predicted life expectancyShort predicted life expectancy Access to radiotherapy centresAccess to radiotherapy centres Limited oncology training of Limited oncology training of
attending physiciansattending physicians Waiting time for radiotherapy Waiting time for radiotherapy
![Page 40: Palliative Radiotherapy](https://reader031.fdocuments.us/reader031/viewer/2022013004/56816807550346895ddd897b/html5/thumbnails/40.jpg)